1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Diabetic Foot Ulcer Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Diabetic Foot Ulcer Treatment Market, by Type
8.1.1. Advanced Wound Care
8.1.1.1. Market Revenue and Forecast
8.1.2. Biologics
8.1.2.1. Market Revenue and Forecast
8.1.3. Dressings
8.1.3.1. Market Revenue and Forecast
9.1. Diabetic Foot Ulcer Treatment Market, by Ulcer Type
9.1.1. Neuropathic Ulcers
9.1.1.1. Market Revenue and Forecast
9.1.2. Neuro-ischemic Ulcers
9.1.2.1. Market Revenue and Forecast
9.1.3. Neuro-ischemic Ulcers
9.1.3.1. Market Revenue and Forecast
10.1. Diabetic Foot Ulcer Treatment Market, by Grade
10.1.1. Grade 1
10.1.1.1. Market Revenue and Forecast
10.1.2. Grade 2
10.1.2.1. Market Revenue and Forecast
10.1.3. Grade 3
10.1.3.1. Market Revenue and Forecast
10.1.4. Grade 4
10.1.4.1. Market Revenue and Forecast
10.1.5. Grade 5
10.1.5.1. Market Revenue and Forecast
11.1. Diabetic Foot Ulcer Treatment Market, by Treatment Type
11.1.1. Wound Care Dressings
11.1.1.1. Market Revenue and Forecast
11.1.2. Wound Care Devices
11.1.2.1. Market Revenue and Forecast
11.1.3. Active Therapies
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. Diabetic Foot Ulcer Treatment Market, by End User
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Home Care
12.1.2.1. Market Revenue and Forecast
12.1.3. Ambulatory Surgical Center
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Type
13.1.2. Market Revenue and Forecast, by Ulcer Type
13.1.3. Market Revenue and Forecast, by Grade
13.1.4. Market Revenue and Forecast, by Treatment Type
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Type
13.1.6.2. Market Revenue and Forecast, by Ulcer Type
13.1.6.3. Market Revenue and Forecast, by Grade
13.1.6.4. Market Revenue and Forecast, by Treatment Type
13.1.7. Market Revenue and Forecast, by End User
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Type
13.1.8.2. Market Revenue and Forecast, by Ulcer Type
13.1.8.3. Market Revenue and Forecast, by Grade
13.1.8.4. Market Revenue and Forecast, by Treatment Type
13.1.8.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type
13.2.2. Market Revenue and Forecast, by Ulcer Type
13.2.3. Market Revenue and Forecast, by Grade
13.2.4. Market Revenue and Forecast, by Treatment Type
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type
13.2.6.2. Market Revenue and Forecast, by Ulcer Type
13.2.6.3. Market Revenue and Forecast, by Grade
13.2.7. Market Revenue and Forecast, by Treatment Type
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Type
13.2.9.2. Market Revenue and Forecast, by Ulcer Type
13.2.9.3. Market Revenue and Forecast, by Grade
13.2.10. Market Revenue and Forecast, by Treatment Type
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Type
13.2.12.2. Market Revenue and Forecast, by Ulcer Type
13.2.12.3. Market Revenue and Forecast, by Grade
13.2.12.4. Market Revenue and Forecast, by Treatment Type
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Type
13.2.14.2. Market Revenue and Forecast, by Ulcer Type
13.2.14.3. Market Revenue and Forecast, by Grade
13.2.14.4. Market Revenue and Forecast, by Treatment Type
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type
13.3.2. Market Revenue and Forecast, by Ulcer Type
13.3.3. Market Revenue and Forecast, by Grade
13.3.4. Market Revenue and Forecast, by Treatment Type
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Type
13.3.6.2. Market Revenue and Forecast, by Ulcer Type
13.3.6.3. Market Revenue and Forecast, by Grade
13.3.6.4. Market Revenue and Forecast, by Treatment Type
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Type
13.3.8.2. Market Revenue and Forecast, by Ulcer Type
13.3.8.3. Market Revenue and Forecast, by Grade
13.3.8.4. Market Revenue and Forecast, by Treatment Type
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Type
13.3.10.2. Market Revenue and Forecast, by Ulcer Type
13.3.10.3. Market Revenue and Forecast, by Grade
13.3.10.4. Market Revenue and Forecast, by Treatment Type
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type
13.3.11.2. Market Revenue and Forecast, by Ulcer Type
13.3.11.3. Market Revenue and Forecast, by Grade
13.3.11.4. Market Revenue and Forecast, by Treatment Type
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type
13.4.2. Market Revenue and Forecast, by Ulcer Type
13.4.3. Market Revenue and Forecast, by Grade
13.4.4. Market Revenue and Forecast, by Treatment Type
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Type
13.4.6.2. Market Revenue and Forecast, by Ulcer Type
13.4.6.3. Market Revenue and Forecast, by Grade
13.4.6.4. Market Revenue and Forecast, by Treatment Type
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Type
13.4.8.2. Market Revenue and Forecast, by Ulcer Type
13.4.8.3. Market Revenue and Forecast, by Grade
13.4.8.4. Market Revenue and Forecast, by Treatment Type
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Type
13.4.10.2. Market Revenue and Forecast, by Ulcer Type
13.4.10.3. Market Revenue and Forecast, by Grade
13.4.10.4. Market Revenue and Forecast, by Treatment Type
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type
13.4.11.2. Market Revenue and Forecast, by Ulcer Type
13.4.11.3. Market Revenue and Forecast, by Grade
13.4.11.4. Market Revenue and Forecast, by Treatment Type
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Type
13.5.2. Market Revenue and Forecast, by Ulcer Type
13.5.3. Market Revenue and Forecast, by Grade
13.5.4. Market Revenue and Forecast, by Treatment Type
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Type
13.5.6.2. Market Revenue and Forecast, by Ulcer Type
13.5.6.3. Market Revenue and Forecast, by Grade
13.5.6.4. Market Revenue and Forecast, by Treatment Type
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Type
13.5.8.2. Market Revenue and Forecast, by Ulcer Type
13.5.8.3. Market Revenue and Forecast, by Grade
13.5.8.4. Market Revenue and Forecast, by Treatment Type
13.5.8.5. Market Revenue and Forecast, by End User
14.1. ConvaTec Group Plc
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. 3M
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. B. Braun Melsungen AG
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Medline Industries, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Coloplast Group
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Smith & Nephew
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Cardinal Health Inc
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Organogenesis Inc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. URGO
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Kerecis
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
